Augustine Lawlor

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Augustine Lawlor
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Augustine Lawlor:

Form 4 holding Chief Operating Officer

LEAP THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
678,456
Estimated value
$214,799
Report date
28 Mar 2025
Price
$0.3166
Ownership
Indirect
Form 4 holding Chief Operating Officer

LEAP THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
19,789
Estimated value
$6,265
Report date
28 Mar 2025
Price
$0.3166
Ownership
Direct
Form 4 holding Chief Operating Officer

LEAP THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
28 Mar 2025
Price
$0.3166
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Operating Officer

LEAP THERAPEUTICS, INC.

Security class
Employee Stock Option (Right to Buy)
Shares / value
85,000
Estimated value
Report date
02 Oct 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cardiovascular Systems Inc

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
27 Apr 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,814
Form 4 holding Director

CATALYST BIOSCIENCES, INC.

Security class
Series Y Preferred Stock
Shares / value
0
Estimated value
Report date
31 Aug 2023
Price
Ownership
By The Lawlor Family Trust UAD 4-17-00
Form 4 holding Chief Operating Officer

LEAP THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
0
Estimated value
Report date
13 Nov 2024
Price
Ownership
Indirect
Underlying class
Common Stock, $0.001 par value per share
Underlying amount

Insider Reports Filed by Augustine Lawlor

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .